Connect your AI

AtriCure ATRC Intangible Amortization

Intangible Amortization at other companies

Pulse Biosciences, Inc.PLSE

$167K+0.6%

Other financials

Income statement

Revenue$141.2M+14.3%

Gross profit$109.3M+18.0%

Operating income$526.0K+109%

Net income$108.0K+102%

EPS (diluted)$0.00+100%

Balance sheet

Cash & equivalents$146.2M+46.3%

Total debt$76.2M-3.1%

Total equity$491.7M+8.2%

Total assets$644.0M+8.8%

Cash flow

Operating cash flow-$4.0M+63.8%

CapEx$3.9M+76.6%

Free cash flow-$7.8M+40.6%

Valuation

Market cap$1.43B-7.9%

Enterprise value$1.36B-11.2%

P/S2.6×-0.6×

Profitability

Gross margin75.6%+0.8pp

Operating margin-5.1%-1.3pp

Net margin-5.6%-1.5pp

FCF margin9.7%—

Returns & leverage

Return on equity-6.1%-1.3pp

Debt / equity0.2×0.0×

Current ratio4.3×+0.2×

Where this comes from

Reported directly by AtriCure in its filing.

Tagged under the XBRL concept us-gaap:AmortizationOfIntangibleAssets.

The official record: AtriCure’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about AtriCure's intangible amortization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is AtriCure's intangible amortization?: AtriCure (ATRC) reported intangible amortization of $2.38M in Q1 2026.
How has AtriCure's intangible amortization changed year-over-year?: AtriCure's intangible amortization increased by 13.0% year-over-year, from $2.11M to $2.38M.
What is the long-term trend for AtriCure's intangible amortization?: Over 4 years (2021 to 2025), AtriCure's intangible amortization has grown at a -43.6% compound annual growth rate (CAGR), from $83.27M to $8.44M.
What does intangible amortization mean?: Non-cash amortization of intangible assets (patents, customer relationships, technology) acquired through M&A or purchases.